Teresa T. Liu

University of Wisconsin–Madison — United States

Medicine · Health Sciences

14h-index1.7kcitations50works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Radiopharmaceutical Chemistry and Applications(17), Prostate Cancer Treatment and Research(15), Urinary Bladder and Prostate Research(13), RNA modifications and cancer(12), Prostate Cancer Diagnosis and Treatment(9)

Publications50 total

Estrogen regulation in the prostate underlies racial disparity in men with benign prostatic hyperplasia
The Journal of Pathology·2025Open Access
ZC3H4, a novel regulator of mitochondrial complex I, impacts prostate stromal cell senescence, attachment, adhesion and anoikis resistance
Cell Death and Disease·2025· 1 citedOpen Access
Lifelong restriction of dietary valine has sex-specific benefits for health and lifespan in mice
2025· 1 citedOpen Access
Prostatic androgen receptor signaling shows an age-related and lobe-specific alteration in mice
Scientific Reports·2024· 3 citedOpen Access
Benign prostatic hyperplasia nodules in patients treated with celecoxib and/or finasteride have reduced levels of NADH dehydrogenase [ubiquinone] iron‐sulfur protein 3, a mitochondrial protein essential for efficient function of the electron transport chain
The Prostate·2024· 1 citedOpen Access
PD03-06 MITOCHONDRIAL COMPLEX I PROTEIN NDUFS3 IS DECREASED IN BENIGN PROSTATIC HYPERPLASIA PATIENTS TREATED WITH CELECOXIB AND/OR FINASTERIDE
The Journal of Urology·2024
Age-Dependent Effects of Voluntary Wheel Running Exercise on Voiding Behavior and Potential Age-Related Molecular Mechanisms in Mice
The Journals of Gerontology Series A·2024· 4 citedOpen Access
Dietary restriction of isoleucine increases healthspan and lifespan of genetically heterogeneous mice
Cell Metabolism·2023· 94 citedOpen Access
Aging-Related Mitochondrial Dysfunction Is Associated With Fibrosis in Benign Prostatic Hyperplasia
The Journals of Gerontology Series A·2023· 12 citedOpen Access
Supplementary Figure 5 from VDR Activity Is Differentially Affected by Hic-5 in Prostate Cancer and Stromal Cells
2023Open Access
Supplementary Figure 3 from VDR Activity Is Differentially Affected by Hic-5 in Prostate Cancer and Stromal Cells
2023Open Access
Supplementary Figure 6 from VDR Activity Is Differentially Affected by Hic-5 in Prostate Cancer and Stromal Cells
2023Open Access
Supplementary Figure 4 from VDR Activity Is Differentially Affected by Hic-5 in Prostate Cancer and Stromal Cells
2023Open Access
Supplementary Figure 3 from VDR Activity Is Differentially Affected by Hic-5 in Prostate Cancer and Stromal Cells
2023Open Access
Supplementary Figure Legends from VDR Activity Is Differentially Affected by Hic-5 in Prostate Cancer and Stromal Cells
2023Open Access
Data from VDR Activity Is Differentially Affected by Hic-5 in Prostate Cancer and Stromal Cells
2023Open Access
Supplementary Figure Legends from VDR Activity Is Differentially Affected by Hic-5 in Prostate Cancer and Stromal Cells
2023Open Access
Supplementary Figure 2 from VDR Activity Is Differentially Affected by Hic-5 in Prostate Cancer and Stromal Cells
2023Open Access
Supplementary Figure 1 from VDR Activity Is Differentially Affected by Hic-5 in Prostate Cancer and Stromal Cells
2023Open Access
Supplementary Figure 1 from VDR Activity Is Differentially Affected by Hic-5 in Prostate Cancer and Stromal Cells
2023Open Access
page 1 of 3Next →

Frequent Co-authors

Donald Defranco(26), William A. Ricke(20), Joshua D. Solomon(17), Marjet D. Heitzer(17), Jan H. Beumer(17), Robert A. Parise(17), Daniel P. Normolle(17), Damien A. Leach(17), Grant Buchanan(17), Katherine S. Barker(8), P. David Rogers(8), Laura E. Pascal(7), Emily A. Ricke(5), Ramin Homayouni(4), Scott R. Bauer(4), Rajiv Dhir(4), Joachim Morschhäuser(3), Zhihua Li(3), Bino John(3), Cara L. Green(3)